DA Davidson Reiterates “Buy” Rating for Phreesia (NYSE:PHR)

Phreesia (NYSE:PHR)‘s stock had its “buy” rating reissued by equities researchers at DA Davidson in a research report issued on Thursday,Benzinga reports. They currently have a $14.00 price objective on the stock. DA Davidson’s price target indicates a potential upside of 45.52% from the stock’s current price.

A number of other equities analysts also recently weighed in on the stock. Wells Fargo & Company reaffirmed an “equal weight” rating and set a $9.00 price target (down from $15.00) on shares of Phreesia in a research note on Wednesday, May 20th. Stephens dropped their price target on shares of Phreesia from $32.00 to $20.00 and set an “overweight” rating on the stock in a research note on Tuesday, March 31st. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $16.00 price target (down from $24.00) on shares of Phreesia in a research note on Tuesday, March 31st. Needham & Company LLC decreased their price objective on shares of Phreesia from $35.00 to $14.00 and set a “buy” rating for the company in a report on Tuesday, March 31st. Finally, Canaccord Genuity Group set a $16.00 price target on shares of Phreesia in a research report on Thursday. Ten analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average target price of $17.76.

Phreesia Trading Up 5.4%

Shares of PHR traded up $0.49 on Thursday, hitting $9.62. 1,628,343 shares of the stock traded hands, compared to its average volume of 1,804,871. The firm has a market capitalization of $594.29 million, a P/E ratio of 319.63 and a beta of 0.89. The company has a quick ratio of 1.53, a current ratio of 1.53 and a debt-to-equity ratio of 0.41. Phreesia has a 1 year low of $7.77 and a 1 year high of $32.76. The stock’s 50 day moving average is $9.53 and its two-hundred day moving average is $13.69.

Phreesia (NYSE:PHR) last released its earnings results on Wednesday, May 27th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.02 by $0.03. Phreesia had a net margin of 0.48% and a return on equity of 3.23%. The firm had revenue of $130.94 million during the quarter, compared to analysts’ expectations of $130.08 million. During the same period in the previous year, the company earned ($0.07) EPS. Phreesia’s revenue for the quarter was up 12.9% on a year-over-year basis. As a group, sell-side analysts predict that Phreesia will post 0.28 earnings per share for the current year.

Insider Transactions at Phreesia

In related news, insider David Linetsky sold 8,332 shares of the firm’s stock in a transaction dated Friday, April 10th. The stock was sold at an average price of $8.07, for a total transaction of $67,239.24. Following the completion of the transaction, the insider owned 224,056 shares of the company’s stock, valued at $1,808,131.92. This trade represents a 3.59% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, General Counsel Allison C. Hoffman sold 14,483 shares of the business’s stock in a transaction that occurred on Friday, April 10th. The stock was sold at an average price of $8.07, for a total transaction of $116,877.81. Following the completion of the sale, the general counsel owned 163,485 shares in the company, valued at $1,319,323.95. The trade was a 8.14% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Over the last ninety days, insiders sold 50,493 shares of company stock worth $461,983. Corporate insiders own 5.20% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently made changes to their positions in the company. EverSource Wealth Advisors LLC increased its position in shares of Phreesia by 1,119.8% in the first quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares in the last quarter. Federated Hermes Inc. purchased a new position in Phreesia during the third quarter valued at approximately $32,000. Van ECK Associates Corp grew its position in Phreesia by 78.7% during the fourth quarter. Van ECK Associates Corp now owns 2,502 shares of the company’s stock valued at $42,000 after purchasing an additional 1,102 shares in the last quarter. New York State Teachers Retirement System bought a new stake in Phreesia in the first quarter worth approximately $44,000. Finally, Rockefeller Capital Management L.P. grew its position in Phreesia by 354.6% in the fourth quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after acquiring an additional 2,149 shares in the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Key Phreesia News

Here are the key news stories impacting Phreesia this week:

• Positive Sentiment: Phreesia beat Wall Street estimates for Q1 fiscal 2027, reporting adjusted EPS of $0.05 versus $0.02 expected and revenue of $130.94 million versus $130.08 million anticipated, with revenue up 12.9% year over year. Article link
• Positive Sentiment: The company also guided to FY2027 revenue of $510 million to $520 million while maintaining adjusted EBITDA of $125 million to $135 million, which signals continued growth and stable profitability expectations. Article link
• Neutral Sentiment: Multiple law firms announced or reiterated class-action litigation tied to alleged misstatements about Phreesia’s growth outlook and Network Solutions segment, with lead-plaintiff deadlines set for July 13, 2026. These notices do not change fundamentals immediately, but they can weigh on investor sentiment. Article link
• Negative Sentiment: The lawsuit claims Phreesia allegedly made misleading statements about long-term growth and demand in its Network Solutions business, creating legal uncertainty and potential distraction for management. Article link

Phreesia Company Profile

Phreesia, Inc (NYSE: PHR) is a provider of patient intake management solutions designed to streamline front-office workflows for healthcare organizations. The company’s cloud-based platform digitizes patient registration, appointment scheduling, insurance verification, consent documentation and payment collection through touchscreen kiosks, tablets and mobile devices. By replacing paper forms and manual processes, Phreesia enhances data accuracy, reduces administrative burden and improves the patient experience.

Founded in 2000 by Chaim Indig and headquartered in Burlington, Massachusetts, Phreesia offers a modular software suite that integrates with electronic medical record (EMR) and practice management systems.